# LMND Medical Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lmnd-medical-group

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.lemonaidhealth.com
- Total disclosed funding: $44M
- Latest round: Series B (Jul 31, 2020)
- Investors on record: 11

## About

Based in California, US, and founded in 2013 by its CEO, Paul Johnson, LMND Medical Group, Inc., doing business as Lemonaid Health, operates as a provider of an artificial-intelligence-based telehealth platform that provides telemedicine services, including an online request for prescriptions and consultations with doctors. In July 2020, Lemonaid Health raised a USD 33 million series B round of funding led by Olive Tree Ventures with participation from Artis Ventures, Correlation Ventures, Hikma Ventures, and Sierra Ventures. As of 2020, Lemonaid Health employs 150 people. In October 2021, 23andMe, Inc., a portfolio company of Altimeter Capital Management, Euclidean Capital, Fidelity Investments, Foundation Asset Management, G Squared, GSK Ventures, National Human Genome Research Institute, NewView Capital, Pegasus Tech Ventures, Roche Venture Fund, SharesPost, and Xfund, acquired LMND Medical Group, Inc. for USD 400 million.

Lemonaid Health offers services such as delivery services, which aid in the direct delivery of medications. Treatment services assist in the treatment of a variety of conditions via video conferences, lab tests, and medicine.

Lemonaid Health makes money by charging a monthly subscription fee that can be canceled at any moment.

## Funding rounds

- Series B, Jul 31, 2020, $33M — Sierra Ventures, Correlation Ventures, ARTIS Ventures, OTV, Health Velocity Capital, Hikma Ventures, Endurance Companies
- Series A, May 22, 2017, $11M — Novartis Venture Fund, Correlation Ventures, Hikma Ventures, Adaptive Health Capital, Vega Ventures, 415 Ventures

## Investors

- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A
- Correlation Ventures (https://capitalatlas.ai/funds/correlation-ventures) — Series A, Series B
- Hikma Ventures (https://capitalatlas.ai/funds/hikma-ventures) — Series A, Series B
- Adaptive Health Capital (https://capitalatlas.ai/funds/adaptive-health-capital) — Series A
- Vega Ventures — Series A
- 415 Ventures (https://capitalatlas.ai/funds/415-ventures) — Series A
- Sierra Ventures (https://capitalatlas.ai/funds/sierra-ventures) — Series B
- ARTIS Ventures (https://capitalatlas.ai/funds/artis-ventures) — Series B
- OTV (https://capitalatlas.ai/funds/otv) — Series B
- Health Velocity Capital (https://capitalatlas.ai/funds/health-velocity-capital) — Series B
- Endurance Companies — Series B